Home >
Medicine Info >
Pegsr 150 MG Tablet
Loading interface...

Pegsr 150 MG Tablet

Manufactured byIpca Laboratories Pvt. Ltd.
ContainsPregabalin
Description
Pegsr 150 MG Tablet is used in the treatment of neuropathic pain (pain due to nerve damage), fibromyalgia (severe muscle pain and tenderness that may occur all over the body), and postherpetic neuralgia (a persistent pain in the areas of the skin where you had shingles, a viral infection that causes a painful rash). It relieves pain by decreasing the release of chemical substances that transfer pain signals from the brain. Pegsr 150 MG Tablet is also used in the treatment of a certain type of anxiety disorder and epilepsy (abnormal electrical activity in the brain causing fits). Pegsr 150 MG Tablet shows side effects like dry mouth, swelling in your arms or feet, weight gain, weakness, confusion, and fatigue. Consult your doctor if these side effects bother you for a long time or become severe. It may also cause drowsiness or dizziness. Avoid driving vehicles or operating machines if you feel dizzy or drowsy after taking this medicine. Pegsr 150 MG Tablet may be taken with or without food. Your doctor will determine the dose and duration of treatment based on your condition. Take it at the same time every day for better results. Avoid taking more than the prescribed dose. Avoid discontinuation of this medicine without consulting your doctor as it may lead to withdrawal symptoms like headache, mood swings, irritation, etc. Pegsr 150 MG Tablet is not recommended if you are allergic to it. Inform your doctor if you have kidney or heart problems. It is not recommended for use in children below 18 years of age as the safety and efficacy data are not clinically established. Consult your doctor if you are pregnant or are breastfeeding.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Pegsr 150 MG Tablet

Avertz 150 MG Tablet
Dr. Reddys Laboratories Ltd.
Pregalin 150 MG Tablet
Torrent Pharmaceuticals Ltd.
Pregastar 150 MG Tablet
Lupin Ltd.
Prynerve 150 MG Tablet
Alkem Laboratories Ltd.
Zylin 150 MG Tablet
Zydus Cadila

Side effects

Major & minor side effects for Pegsr 150 MG Tablet

  • Difficulty in breathing
  • Chest tightness
  • Diarrhoea
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Unusual tiredness and weakness
  • Blurred vision
  • Dizziness
  • Dry mouth
  • Headache
  • Lack of coordination
  • Loss of bladder control
  • Anxiety and nervousness
  • Confusion
  • Weight gain
  • Drowsiness

Uses of Pegsr 150 MG Tablet

What is it prescribed for?

  • Diabetic Neuropathy
  • Postherpetic Neuralgia
  • Epilepsy
  • Fibromyalgia
  • Neuropathic pain
  • Generalized anxiety disorder
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time Pegsr 150 MG Tablet takes to show its action is not known.
  • How long do the effects of this medicine last?
    The amount of time for which Pegsr 150 MG Tablet remains active in your body is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Avoid consumption of alcohol if you are taking Pegsr 150 MG Tablet. It may increase the risk of side effects like dizziness, drowsiness, and impaired ability to think. Avoid performing activities that require high mental alertness like driving vehicles or operating machines.
  • Is this a habit forming medicine?
    Pegsr 150 MG Tablet has a low abuse potential with limited physical and psychological dependence.
  • Can this medicine be taken during pregnancy?
    Pegsr 150 MG Tablet is not recommended for use during pregnancy unless necessary. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Pegsr 150 MG Tablet is not recommended for use while breastfeeding as it may pass into breastmilk. Consult your doctor if you are breastfeeding.

Allergy

Pegsr 150 MG Tablet is not recommended if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Pegsr 150 MG Tablet is not recommended for use during pregnancy unless necessary. Consult your doctor if you are pregnant.

Breast-feeding

Pegsr 150 MG Tablet is not recommended for use while breastfeeding as it may pass into breastmilk. Consult your doctor if you are breastfeeding.
General warnings

Kidney disease

Use Pegsr 150 MG Tablet with caution if you have kidney problems as it may cause further kidney damage. Your doctor may suggest tests to monitor the kidney function while you are taking this medicine.

Suicidal tendencies

Pegsr 150 MG Tablet may increase the risk of suicidal thoughts or behaviour. Hence, close observation for change in mood or behaviour is necessary while you are taking this medicine.

Driving or operating machines

Pegsr 150 MG Tablet may increase the risk of drowsiness, dizziness, difficulty concentrating, etc. Hence, avoid performing activities such as driving vehicles or operating machines if you experience any of these symptoms.

Withdrawal symptoms

Sudden discontinuation of Pegsr 150 MG Tablet may lead to withdrawal symptoms such as irritability, mood swings, depression, nervousness, convulsions (fits), etc. Do not stop the use of this medicine without consulting your doctor.

Heart disease

Use Pegsr 150 MG Tablet with caution if you have heart problems as it may cause abnormal heart rhythm which could result in further complications. This medicine may also cause retention of fluid in your body and increase the risk of heart failure. It is more likely to occur in the elderly with compromised heart function. Hence, your doctor will closely monitor the functioning of your heart during treatment with this medicine.

Other medicines

Pegsr 150 MG Tablet may interact with other medicines and cause side effects. Hence, inform your doctor about all your current medicines including any herbs and supplements before beginning the treatment.

Use in children

Pegsr 150 MG Tablet is not recommended for use in children below 18 years of age as the safety and efficacy data are not clinically established.

Potential for abuse

Pegsr 150 MG Tablet may cause dependency (being habituated to the medicine, unable to function normally without it), especially if you have used other recreational medicines (medicines used for enjoyment and leisure purposes rather than for medical reasons) in the past. Inform your doctor if you had a history of substance abuse before taking this medicine.

High creatinine kinase levels

Myopathy is a condition in which the muscles do not function properly leading to muscle weakness. Use Pegsr 150 MG Tablet with caution in such conditions as it may cause an increase in the creatine kinase levels. Thus, it may worsen your condition.

Missed Dose

Take the missed dose of Pegsr 150 MG Tablet as soon as you remember. If it is time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Never take more than the prescribed dose of Pegsr 150 MG Tablet. Seek emergency medical treatment in case of an overdose for further guidance.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Avoid consumption of alcohol if you are taking Pegsr 150 MG Tablet. It may increase the risk of side effects like dizziness, drowsiness, and impaired ability to think. Avoid performing activities that require high mental alertness like driving vehicles or operating machines.
Interaction with Medicine

Lorazepam

Buprenorphine

Oxycodone

Propoxyphene

Azatadine

Ramipril

Disease interactions

Angioedema

Use Pegsr 150 MG Tablet with caution if you have a history of angioedema (swelling of the inner layer of the skin). This medicine may further increase the risk of angioedema. Your doctor may prescribe an alternative medicine based on your clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Pegsr 150 MG Tablet may be taken with or without food. Do not break, chew, or crush the tablet. Take this medicine exactly as advised by your doctor for the recommended duration. Avoid taking larger or smaller quantities than recommended. Take this medicine at the same time every day for the ease of remembering. Inform your doctor if your symptoms do not improve or if you experience any side effects that persist or worsen. Avoid consumption of alcohol during treatment with Pegsr 150 MG Tablet as it may increase the risk of side effects.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works
Pegsr 150 MG Tablet acts by reducing the action of certain chemical substances in the brain. Thus, it impairs the transmission of pain signals from the brain and relieves pain.
Legal Status

Approved

Unknown

Approved

Approved

Classification

Category

Gamma-aminobutyric acid analogs

Schedule

Schedule H

Drugs, H., 2021. Pregabalin: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 20 October 2021].

https://medlineplus.gov/druginfo/meds/a605045.html

Medicines.org.uk. 2021. Pregabalin Neuraxpharm 50 mg tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: [Accessed 20 October 2021].

https://www.medicines.org.uk/emc/product/10773/smpc#PRODUCTINFO

Pubchem.ncbi.nlm.nih.gov. 2021. Pregabalin. [online] Available at: [Accessed 20 October 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Pregabalin

Medsafe.govt.nz. 2021. [online] Available at: [Accessed 20 October 2021].

http://www.medsafe.govt.nz/consumers/cmi/l/lyrica.pdf

Rad-ar.or.jp. 2021. Search results detail| Kusurino-Shiori(Drug information Sheet). [online] Available at: [Accessed 20 October 2021].

https://www.rad-ar.or.jp/siori/english/kekka.cgi?n=38861

Accessdata.fda.gov. 2021. [online] Available at: [Accessed 23 November 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021446s035,022488s013lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 18 Jan 2023

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.